Coaerosolization of phosphodiesterase inhibitors markedly enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension. Maintenance of lung selectivity.
about
Inhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migrationIloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungsChronic obstructive pulmonary disease, pollution, pulmonary vascular disease, transplantation, pleural disease, and lung cancer in AJRCCM 2001.Pharmacotherapy of acute respiratory distress syndrome.Phosphodiesterase 5 inhibitors augment UT-15C-stimulated ATP release from erythrocytes of humans with pulmonary arterial hypertensionInhaled iloprost for the control of pulmonary hypertension.Review of inhaled iloprost for the control of pulmonary artery hypertension in childrenMeasles-induced respiratory distress, air-leak and ARDS.Opposing roles of leukotrienes and prostaglandins in fibrotic lung disease.DA-8159, a potent cGMP phosphodiesterase inhibitor, attenuates monocrotaline-induced pulmonary hypertension in rats.A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats.DA-8159, a new PDE5 inhibitor, attenuates the development of compensatory right ventricular hypertrophy in a rat model of pulmonary hypertension.Treating pulmonary hypertension post cardiopulmonary bypass in pigs: milrinone vs. sildenafil analog.Potent effects of aerosol compared with intravenous treprostinil on the pulmonary circulation.Selective pulmonary vasodilation with inhaled aerosolized milrinone in heart transplant candidates.Effects of prostacyclin and milrinone on pulmonary hemodynamics in newborn lambs with persistent pulmonary hypertension induced by ductal ligation.The optimization of iloprost inhalation under moderate flow of oxygen therapy in severe pulmonary arterial hypertension.
P2860
Q24812224-4CD290BA-DDA9-4A33-BA56-3D6459AAD4B9Q28218337-E4447366-3AFD-4D25-83D8-8C32CF3D46ADQ34550155-2E26B9FB-280B-4D43-8777-DE965302BCBDQ34706893-838EEED3-B930-40B2-A03F-9B52196F0F13Q37070945-9EDD7900-6ACD-444A-8602-DA79E47231ABQ37202163-6E89DA86-1FE8-46A9-A011-AB895688F081Q37479077-73B6DF70-EC3B-460F-90E7-FF03A0DC7491Q37655590-0D4FBE27-94F3-4D23-92BE-BE3C9F6C9927Q37754750-531138DC-4F06-4DE3-BD8B-183B4213AC31Q44580202-828AA00B-D4A4-4B89-A3A0-B592DC5308B3Q44606457-8B9AA270-F1B5-4427-B956-635B719E3721Q44715956-E3CE0A75-870E-432E-A3A9-EC7F7747A067Q46327304-FEFA71A0-FAA8-4523-8DDB-6885EF4D51C1Q46686053-A73EE3A7-40B7-46AB-8E96-FCA321E40705Q46834789-74EF690B-2DBB-430D-844C-1ED7D9B410D9Q52006478-25067239-9DB6-462D-9B7B-0233E95DA732Q55515005-FD4B1A0F-A9AF-4F68-B46D-E9C47AE30E25
P2860
Coaerosolization of phosphodiesterase inhibitors markedly enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension. Maintenance of lung selectivity.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Coaerosolization of phosphodie ...... intenance of lung selectivity.
@en
Coaerosolization of phosphodie ...... intenance of lung selectivity.
@nl
type
label
Coaerosolization of phosphodie ...... intenance of lung selectivity.
@en
Coaerosolization of phosphodie ...... intenance of lung selectivity.
@nl
prefLabel
Coaerosolization of phosphodie ...... intenance of lung selectivity.
@en
Coaerosolization of phosphodie ...... intenance of lung selectivity.
@nl
P2093
P2860
P1476
Coaerosolization of phosphodie ...... intenance of lung selectivity.
@en
P2093
Ghofrani HA
Grimminger F
Schermuly RT
Walmrath D
Weissmann N
P2860
P304
P356
10.1164/AJRCCM.164.9.2105060
P407
P577
2001-11-01T00:00:00Z